You are here

Article info

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Naltrexone–buproprion causes weight loss in overweight and obese adults

Authors

  1. Correspondence to Steven R Smith
    Translational Research Institute for Metabolism and Diabetes; Florida Hospital, Sanford-Burnham Medical Research Institute, 2566 Lee Rd, Winter Park, FL 32789; steven.r.smith.md{at}flhosp.org
View Full Text

Citation

Smith SR
Naltrexone–buproprion causes weight loss in overweight and obese adults
BMJ Evidence-Based Medicine 2011;16:53-54.

Publication history

  • First published January 12, 2011.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions